Wes Ely
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID (NCT06631287) | Wes Ely | 2024-10-21 |
Track Wes Ely automatically
Every clearance here is in the API, with alerts when new ones post.